Chugai Pharmaceutical Co., Ltd.
4519.TJapan
40 filed reports · 370 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
40 reports · Sep 2016 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Q1 · quarterly securities reportEDINET | 8 | 936 | Mar 2017 to Mar 2024 |
| Q3 · quarterly securities reportEDINET | 8 | 984 | Sep 2016 to Sep 2023 |
| Half Year · quarterly securities reportEDINET | 7 | 890 | Jun 2017 to Jun 2023 |
| Annual · amended annual securities reportEDINET | 6 | 1,498 | Dec 2017 to Dec 2023 |
| Annual · annual securities reportEDINET | 4 | 1,275 | Dec 2016 to Dec 2025 |
| Half Year · half-year securities reportEDINET | 3 | 545 | Jun 2024 to Jun 2026 |
| Q1 · quarterly earnings release (kessan tanshin)EDINET | 2 | 237 | Mar 2025 to Mar 2026 |
| Q3 · quarterly earnings release (kessan tanshin)EDINET | 2 | 238 | Sep 2024 to Sep 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 H1 | half-year securities report | Jun 30, 2026 | Jul 27, 2026 | 234 | Open |
| FY2026 Q1 | quarterly earnings release (kessan tanshin) | Mar 31, 2026 | Apr 24, 2026 | 181 | Open |
| FY2025 | annual securities report | Dec 31, 2025 | Mar 25, 2026 | 543 | Open |
| FY2025 Q3 | quarterly earnings release (kessan tanshin) | Sep 30, 2025 | Oct 24, 2025 | 182 | Open |
| FY2025 H1 | half-year securities report | Jun 30, 2025 | Jul 25, 2025 | 156 | Open |
| FY2025 Q1 | quarterly earnings release (kessan tanshin) | Mar 31, 2025 | Apr 24, 2025 | 56 | Open |
| FY2024 | annual securities report | Dec 31, 2024 | Mar 27, 2025 | 287 | Open |
| FY2024 Q3 | quarterly earnings release (kessan tanshin) | Sep 30, 2024 | Oct 25, 2024 | 56 | Open |
| FY2024 H1 | half-year securities report | Jun 30, 2024 | Jul 26, 2024 | 155 | Open |
| FY2024 Q1 | quarterly securities report | Mar 31, 2024 | Apr 25, 2024 | 227 | Open |
| FY2023 | amended annual securities report | Dec 31, 2023 | Jul 26, 2024 | 346 | Open |
| FY2023 Q3 | quarterly securities report | Sep 30, 2023 | Oct 25, 2023 | 290 | Open |
Financial data
370 concepts · 6,603 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
IFRS206 concepts · 5,234 facts · Sep 2015 to Jun 2026
- EPS (Basic)87 · Sep 2015 to Jun 2026
- Net Income87 · Sep 2015 to Jun 2026
- Revenue87 · Sep 2015 to Jun 2026
- Comprehensive Income Attributable to Owners of Parent80 · Sep 2015 to Jun 2026
- EPS (Diluted)80 · Sep 2015 to Jun 2026
- Pretax Income80 · Sep 2015 to Jun 2026
- Profit Attributable to Owners of Parent80 · Sep 2015 to Jun 2026
- Total Comprehensive Income80 · Sep 2015 to Jun 2026
- Cash and Equivalents74 · Sep 2015 to Jun 2026
- Total Assets74 · Sep 2015 to Jun 2026
- Financing Cash Flow70 · Sep 2015 to Jun 2026
- Investing Cash Flow70 · Sep 2015 to Jun 2026
- Operating Cash Flow70 · Sep 2015 to Jun 2026
- Ratio of owners' equity to gross assets (IFRS), Key financial data66 · Sep 2015 to Jun 2026
- Stockholders Equity55 · Dec 2017 to Jun 2026
- Total equity49 · Sep 2016 to Jun 2026
- Deferred tax assets (IFRS)48 · Dec 2018 to Jun 2026
- Deferred tax liabilities (IFRS)48 · Dec 2018 to Jun 2026
- Equity Attributable to Owners of Parent48 · Dec 2018 to Jun 2026
- Income taxes payable - CL (IFRS)48 · Dec 2018 to Jun 2026
- Intangible assets (IFRS)48 · Dec 2018 to Jun 2026
- Inventory48 · Dec 2018 to Jun 2026
- Other current assets - CA (IFRS)48 · Dec 2018 to Jun 2026
- Other current liabilities - CL (IFRS)48 · Dec 2018 to Jun 2026
GAAP164 concepts · 1,369 facts · Dec 2015 to Dec 2025
- Accounts payable - other11 · Dec 2015 to Dec 2025
- Accounts payable - trade11 · Dec 2015 to Dec 2025
- Accounts receivable - other11 · Dec 2015 to Dec 2025
- Accounts receivable - trade11 · Dec 2015 to Dec 2025
- Accrued expenses11 · Dec 2015 to Dec 2025
- Allowance for doubtful accounts-IOA-by group11 · Dec 2015 to Dec 2025
- Asset retirement obligations-NCL11 · Dec 2015 to Dec 2025
- Buildings, net11 · Dec 2015 to Dec 2025
- Capital surplus11 · Dec 2015 to Dec 2025
- Cash and deposits11 · Dec 2015 to Dec 2025
- Construction in progress11 · Dec 2015 to Dec 2025
- Cost of Revenue11 · Dec 2015 to Dec 2025
- Deferred gains or losses on hedges11 · Dec 2015 to Dec 2025
- Deposits received11 · Dec 2015 to Dec 2025
- Disposal of treasury shares11 · Dec 2015 to Dec 2025
- Dividend paid per share11 · Dec 2015 to Dec 2025
- Dividends of surplus11 · Dec 2015 to Dec 2025
- EPS (Basic)11 · Dec 2015 to Dec 2025
- EPS (Diluted)11 · Dec 2015 to Dec 2025
- Equity-to-asset ratio, Key financial data11 · Dec 2015 to Dec 2025
- Extraordinary income11 · Dec 2015 to Dec 2025
- Extraordinary losses11 · Dec 2015 to Dec 2025
- Gain on sale of non-current assets - EI11 · Dec 2015 to Dec 2025
- General reserve11 · Dec 2015 to Dec 2025
Segments
Figures broken down by business line, region, product or another axis the company reports on.
No segment breakdowns.
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.